Mr. Timothy Ko reports

ENTHEON BIOMEDICAL ANNOUNCES CHANGE OF OFFICERS

Entheon Biomedical Corp. has terminated Andrew Hegle's position as chief science officer, effective today. Mr. Hegle will continue on the company's board of directors.

About Entheon Biomedical Corp.

Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.